Orexins (hypocretins) contribute to fear and avoidance in rats exposed to a single episode of footshocks

Brain Structure and Function

Volumn 219, Issue 6, 2014, Pages 2103-2118

  Chen, Xiaoyu ^a   Wang, Huiying ^a   Lin, Zhang ^a   Li, Sa ^a   Li, Yonghui ^b   Bergen, Hugo T ^a   Vrontakis, Maria E ^a   Kirouac, Gilbert J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b INSTITUTE OF PSYCHOLOGY   (China)

Author keywords

Anxiety; Arousal; Fear; Hypocretin; Orexin; Post traumatic stress disorder

Indexed keywords

1 [2 [(1 METHYL 2 BENZIMIDAZOLYL)THIO]ACETYL] N (2 PHENYLPHENYL) 2 PYRROLIDINECARBOXAMIDE; MESSENGER RNA; OREXIN; BENZIMIDAZOLE DERIVATIVE; N-BIPHENYL-2-YL-1-(((1-METHYL-1H-BENZIMIDAZOL-2-YL)SULFANYL)ACETYL)PROLINAMIDE; NEUROPEPTIDE; OREXINS; PROLINE; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; FEAR; FOOTSHOCK; IMMOBILITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; T-MAZE TEST; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ELECTROSTIMULATION; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANXIETY; AVOIDANCE LEARNING; BENZIMIDAZOLES; ELECTRIC STIMULATION; FEAR; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEUROPEPTIDES; PROLINE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STRESS, PSYCHOLOGICAL;

EID: 84926131372     PISSN: 18632653     EISSN: 18632661     Source Type: Journal    
DOI: 10.1007/s00429-013-0626-3     Document Type: Article

References (65)

1. Bergman JM, Roecker AJ, Mercer SP, Bednar RA, Reiss DR, Ransom RW, Meacham Harrell C, Pettibone DJ, Lemaire W, Murphy KL, Li C, Prueksaritanont T, Winrow CJ, Renger JJ, Koblan KS, Hartman GD, Coleman PJ (2008) Proline bis-amides as potent dual orexin receptor antagonists. Bioorg Med Chem Lett 18:1425–1430
2. Berridge CW, Espana RA, Vittoz NM (2010) Hypocretin/orexin in arousal and stress. Brain Res 1314:91–102
3. Bonne O, Grillon C, Vythilingam M, Neumeister A, Charney DS (2004) Adaptive and maladaptive psychobiological responses to severe psychological stress: implications for the discovery of novel pharmacotherapy. Neurosci Biobehav Rev 28:65–94
4. Boutrel B, de Lecea L (2008) Addiction and arousal: the hypocretin connection. Physiol Behav 93:947–951
5. Boutrel B, Cannella N, de Lecea L (2010) The role of hypocretin in driving arousal and goal-oriented behaviors. Brain Res 1314:103–111
6. Bruijnzeel AW, Stam R, Wiegant VM (2001a) Effect of a benzodiazepine receptor agonist and corticotropin-releasing hormone receptor antagonists on long-term foot-shock-induced increase in defensive withdrawal behavior. Psychopharmacology 158:132–139
7. Bruijnzeel AW, Stam R, Wiegant VM (2001b) LY354740 attenuates the expression of long-term behavioral sensitization induced by a single session of foot shocks. Eur J Pharmacol 426:77–80
8. Carobrez AP, Bertoglio LJ (2005) Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29:1193–1205
9. Chen X, Li Y, Li S, Kirouac GJ (2012) Early fear as a predictor of avoidance in a rat model of post-traumatic stress disorder. Behav Brain Res 226:112–117
10. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS 2nd, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 95:322–327
11. de Paula Soares V, Vicente MA, Biojone C, Zangrossi H Jr, Guimaraes FS, Joca SR (2011) Distinct behavioral consequences of stress models of depression in the elevated T-maze. Behav Brain Res 225:590–595
12. Espana RA, Valentino RJ, Berridge CW (2003) Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration. Neuroscience 121:201–217
13. Estabrooke IV, McCarthy MT, Ko E, Chou TC, Chemelli RM, Yanagisawa M, Saper CB, Scammell TE (2001) Fos expression in orexin neurons varies with behavioral state. J Neurosci 21:1656–1662
14. Fanselow MS (1980) Conditioned and unconditional components of post-shock freezing. Pavlov J Biol Sci 15:177–182
15. Furlong TM, Vianna DM, Liu L, Carrive P (2009) Hypocretin/orexin contributes to the expression of some but not all forms of stress and arousal. Eur J Neurosci 30:1603–1614
16. Graeff FG, Netto CF, Zangrossi H Jr (1998) The elevated T-maze as an experimental model of anxiety. Neurosci Biobehav Rev 23:237–246
17. Harris GC, Aston-Jones G (2006) Arousal and reward: a dichotomy in orexin function. Trends Neurosci 29:571–577
18. Harris GC, Wimmer M, Aston-Jones G (2005) A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437:556–559
19. Heydendael W, Sharma K, Iyer V, Luz S, Piel D, Beck S, Bhatnagar S (2011) Orexins/hypocretins act in the posterior paraventricular thalamic nucleus during repeated stress to regulate facilitation to novel stress. Endocrinology 152(1):4738–4752. doi:10.1210/en.2011-1652
20. Ida T, Nakahara K, Murakami T, Hanada R, Nakazato M, Murakami N (2000) Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun 270:318–323
21. Johnson PL, Truitt W, Fitz SD, Minick PE, Dietrich A, Sanghani S, Traskman-Bendz L, Goddard AW, Brundin L, Shekhar A (2010) A key role for orexin in panic anxiety. Nat Med 16:111–115
22. Johnson PL, Samuels BC, Fitz SD, Federici LM, Hammes N, Early MC, Truitt W, Lowry CA, Shekhar A (2012) Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network. Physiol Behav 107:733–742
23. Kayaba Y, Nakamura A, Kasuya Y, Ohuchi T, Yanagisawa M, Komuro I, Fukuda Y, Kuwaki T (2003) Attenuated defense response and low basal blood pressure in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol 285:R581–R593
24. Kirouac GJ, Parsons MP, Li S (2005) Orexin (hypocretin) innervation of the paraventricular nucleus of the thalamus. Brain Res 1059:179–188
25. Li S, Kirouac GJ (2008) Projections from the paraventricular nucleus of the thalamus to the forebrain, with special emphasis on the extended amygdala. J Comp Neurol 506:263–287
26. Li Y, Li S, Sui N, Kirouac GJ (2009) Orexin-A acts on the paraventricular nucleus of the midline thalamus to inhibit locomotor activity in rats. Pharmacol Biochem Behav 93:506–514
27. Li Y, Li S, Wei C, Wang H, Sui N, Kirouac GJ (2010a) Changes in emotional behavior produced by orexin microinjections in the paraventricular nucleus of the thalamus. Pharmacol Biochem Behav 95:121–128
28. Li Y, Li S, Wei C, Wang H, Sui N, Kirouac GJ (2010b) Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats. Psychopharmacology 212:251–265
29. Louvart H, Maccari S, Ducrocq F, Thomas P, Darnaudery M (2005) Long-term behavioural alterations in female rats after a single intense footshock followed by situational reminders. Psychoneuroendocrinology 30:316–324
30. Louvart H, Maccari S, Lesage J, Leonhardt M, Dickes-Coopman A, Darnaudery M (2006) Effects of a single footshock followed by situational reminders on HPA axis and behaviour in the aversive context in male and female rats. Psychoneuroendocrinology 31:92–99
31. Lungwitz EA, Molosh A, Johnson PL, Harvey BP, Dirks RC, Dietrich A, Minick P, Shekhar A, Truitt WA (2012) Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats. Physiol Behav 107:726–732
32. Mikics E, Baranyi J, Haller J (2008a) Rats exposed to traumatic stress bury unfamiliar objects—a novel measure of hyper-vigilance in PTSD models? Physiol Behav 94:341–348
33. Mikics E, Toth M, Varju P, Gereben B, Liposits Z, Ashaber M, Halasz J, Barna I, Farkas I, Haller J (2008b) Lasting changes in social behavior and amygdala function following traumatic experience induced by a single series of foot-shocks. Psychoneuroendocrinology 33:1198–1210
34. Mileykovskiy BY, Kiyashchenko LI, Siegel JM (2005) Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 46:787–798
35. Nollet M, Gaillard P, Minier F, Tanti A, Belzung C, Leman S (2011) Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression. Neuropharmacology 61:336–346
36. Parsons MP, Li S, Kirouac GJ (2007) Functional and anatomical connection between the paraventricular nucleus of the thalamus and dopamine fibers of the nucleus accumbens. J Comp Neurol 500:1050–1063
37. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18:9996–10015
38. Pinheiro SN, Del-Ben CM, Zangrossi H Jr, Graeff FG (2008) Anxiolytic and panicolytic effects of escitalopram in the elevated T-maze. J Psychopharmacol 22:132–137
39. Rachalski A, Alexandre C, Bernard JF, Saurini F, Lesch KP, Hamon M, Adrien J, Fabre V (2009) Altered sleep homeostasis after restraint stress in 5-HTT knock-out male mice: a role for hypocretins. J Neurosci 29:15575–15585
40. Ramos A, Mormede P (1998) Stress and emotionality: a multidimensional and genetic approach. Neurosci Biobehav Rev 22:33–57
41. Rau V, DeCola JP, Fanselow MS (2005) Stress-induced enhancement of fear learning: an animal model of posttraumatic stress disorder. Neurosci Biobehav Rev 29:1207–1223
42. Rodgers RJ, Dalvi A (1997) Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev 21:801–810
43. Rodgers RJ, Ishii Y, Halford JC, Blundell JE (2002) Orexins and appetite regulation. Neuropeptides 36:303–325
44. Rodgers RJ, Wright FL, Snow NF, Taylor LJ (2013) Orexin-1 receptor antagonism fails to reduce anxiety-like behaviour in either plus-maze-naive or plus-maze-experienced mice. Behav Brain Res 243:213–219
45. Sakamoto F, Yamada S, Ueta Y (2004) Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul Pept 118:183–191
46. Sakurai T (2007) The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 8:171–181
47. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573–585
48. Sawai N, Ueta Y, Nakazato M, Ozawa H (2010) Developmental and aging change of orexin-A and -B immunoreactive neurons in the male rat hypothalamus. Neurosci Lett 468(1):51–55
49. Siegmund A, Wotjak CT (2007) A mouse model of posttraumatic stress disorder that distinguishes between conditioned and sensitised fear. J Psychiatry Res 41:848–860
50. Stam R (2007) PTSD and stress sensitisation: a tale of brain and body Part 1: human studies. Neurosci Biobehav Rev 31:530–557
51. Steiner MA, Lecourt H, Jenck F (2012) The brain orexin system and almorexant in fear-conditioned startle reactions in the rat. Psychopharmacology 223:465–475
52. Suzuki M, Beuckmann CT, Shikata K, Ogura H, Sawai T (2005) Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Res 1044:116–121
53. Taheri S, Zeitzer JM, Mignot E (2002) The role of hypocretins (orexins) in sleep regulation and narcolepsy. Annu Rev Neurosci 25:283–313
54. Thompson JL, Borgland SL (2011) A role for hypocretin/orexin in motivation. Behav Brain Res 217:446–453
55. van Dijken HH, Mos J, van der Heyden JA, Tilders FJ (1992a) Characterization of stress-induced long-term behavioural changes in rats: evidence in favor of anxiety. Physiol Behav 52:945–951
56. Van Dijken HH, Tilders FJ, Olivier B, Mos J (1992b) Effects of anxiolytic and antidepressant drugs on long-lasting behavioural deficits resulting from one short stress experience in male rats. Psychopharmacology 109:395–402
57. Viana MB, Tomaz C, Graeff FG (1994) The elevated T-maze: a new animal model of anxiety and memory. Pharmacol Biochem Behav 49:549–554
58. Wall PM, Messier C (2001) Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior. Neurosci Biobehav Rev 25:275–286
59. Winrow CJ, Tanis KQ, Reiss DR, Rigby AM, Uslaner JM, Uebele VN, Doran SM, Fox SV, Garson SL, Gotter AL, Levine DM, Roecker AJ, Coleman PJ, Koblan KS, Renger JJ (2010) Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure. Neuropharmacology 58:185–194
60. Winsky-Sommerer R, Yamanaka A, Diano S, Borok E, Roberts AJ, Sakurai T, Kilduff TS, Horvath TL, de Lecea L (2004) Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 24:11439–11448
61. Yamamoto Y, Ueta Y, Date Y, Nakazato M, Hara Y, Serino R, Nomura M, Shibuya I, Matsukura S, Yamashita H (1999) Down regulation of the prepro-orexin gene expression in genetically obese mice. Brain Res Mol Brain Res 65:14–22
62. Yehuda R, LeDoux J (2007) Response variation following trauma: a translational neuroscience approach to understanding PTSD. Neuron 56:19–32
63. Zangrossi H Jr, Graeff FG (1997) Behavioral validation of the elevated T-maze, a new animal model of anxiety. Brain Res Bull 44:1–5
64. Zhang W, Sunanaga J, Takahashi Y, Mori T, Sakurai T, Kanmura Y, Kuwaki T (2010) Orexin neurons are indispensable for stress-induced thermogenesis in mice. J Physiol 588:4117–4129
65. Zhu L, Onaka T, Sakurai T, Yada T (2002) Activation of orexin neurones after noxious but not conditioned fear stimuli in rats. NeuroReport 13:1351–1353